Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Brooksville › NPI 1013961838
Hospital

Hca Health Services of Florida, INC.

Hca Health Services of Florida, INC. was paid $10.61M by Medicaid between Jan 2018 and Dec 2024, across 153 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.

33Billing provider infoHCA HEALTH SERVICES OF FLORIDA, INC.
BROOKSVILLE, FL 34613
33aNPI1013961838assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.61M
24GClaims407,483
24DCodes billed153
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#48 of 163
Median peer was paid$4.77M
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201827,123$235K
201979,628$1.29M
202070,879$1.14M
202181,540$2.29M
202284,419$2.93M
202342,294$1.69M
2024incomplete21,600$1.03M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 31% 36,263 33,421 $3.25M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 19% 29,789 25,822 $2.07M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.4% 8,301 7,891 $780K
74177 Computed tomography, abdomen and pelvis; with contrast material 6.0% 3,628 3,247 $641K
80053 Comprehensive metabolic panel 5.6% 27,901 22,551 $595K
70450 Computed tomography, head or brain; without contrast material 3.4% 3,239 2,693 $361K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.4% 4,883 4,199 $359K
99281 Emergency department visit for the evaluation and management, self-limited or minor 3.1% 3,016 2,812 $327K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.1% 1,731 1,519 $221K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 2,579 564 $113K
G0378 Hospital observation service, per hour 1.0% 4,266 2,278 $111K
96361 Intravenous infusion, hydration; each additional hour <1% 1,254 1,146 $93K
141 more codes
80048 Basic metabolic panel (calcium, ionized) <1% 3,164 $93K
71275 Computed tomographic angiography, chest, with contrast material <1% 511 $86K
76830 Ultrasound, transvaginal <1% 1,161 $83K
87070 <1% 3,992 $79K
87400 <1% 11,625 $73K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,274 $68K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,367 $65K
86850 <1% 2,628 $64K
81001 <1% 10,797 $58K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 11,647 $57K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,415 $51K
72125 Computed tomography, cervical spine; without contrast material <1% 1,186 $43K
71045 Radiologic examination, chest; single view <1% 11,307 $40K
81003 <1% 5,758 $40K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,928 $37K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,134 $36K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 912 $36K
84703 <1% 2,160 $36K
76818 <1% 985 $35K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,056 $32K
85027 <1% 31,982 $31K
71046 Radiologic examination, chest; 2 views <1% 3,257 $28K
76801 <1% 784 $28K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 489 $25K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,472 $25K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,877 $24K
74018 <1% 1,169 $20K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 292 $20K
84702 <1% 3,410 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 13,563 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 402 $19K
73610 <1% 1,005 $19K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 169 $17K
87077 <1% 1,636 $16K
73630 <1% 1,067 $16K
73564 <1% 985 $15K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 15,446 $15K
73130 <1% 716 $14K
87420 <1% 2,301 $13K
A9270 Non-covered item or service <1% 7,012 $12K
82731 <1% 82 $12K
73110 <1% 562 $11K
73030 <1% 574 $10K
84112 <1% 210 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 582 $8K
81025 <1% 2,960 $7K
86900 <1% 3,065 $7K
70480 <1% 259 $7K
84484 <1% 7,187 $7K
12001 <1% 71 $6K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 74 $6K
12011 <1% 61 $5K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 609 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,374 $4K
85610 <1% 6,300 $4K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 28 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,117 $4K
86901 <1% 3,014 $3K
76775 <1% 55 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 7,283 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 5,605 $3K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 262 $3K
87040 <1% 2,718 $3K
87210 <1% 324 $2K
83735 <1% 5,387 $2K
82570 <1% 301 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 480 $2K
84443 Thyroid stimulating hormone (TSH) <1% 1,536 $2K
73090 <1% 67 $2K
83690 <1% 5,560 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 225 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,456 $2K
93970 <1% 68 $2K
86140 <1% 1,510 $2K
73080 <1% 128 $2K
85730 <1% 4,364 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 192 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,787 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,283 $1K
80061 Lipid panel <1% 646 $1K
97161 <1% 46 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 165 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,547 $973.02
J3010 Injection, fentanyl citrate, 0.1 mg <1% 168 $920.29
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 87 $784.29
85379 <1% 540 $771.76
72110 <1% 59 $755.08
C1769 Guide wire <1% 29 $708.41
J7050 Infusion, normal saline solution, 250 cc <1% 918 $690.16
82150 <1% 2,286 $646.15
83036 Hemoglobin; glycosylated (A1C) <1% 195 $619.23
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,216 $598.35
73590 <1% 27 $592.43
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 429 $560.12
87186 <1% 1,349 $484.22
84439 <1% 131 $419.57
85652 <1% 624 $413.26
73502 <1% 30 $369.49
83880 <1% 1,567 $366.28
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 210 $342.18
84145 <1% 90 $340.34
97116 <1% 28 $311.93
J1644 Injection, heparin sodium, per 1000 units <1% 29 $303.01
83605 <1% 1,880 $282.41
36415 Collection of venous blood by venipuncture <1% 438 $273.61
84156 <1% 319 $265.32
84100 <1% 1,443 $258.30
80076 <1% 75 $258.04
90714 <1% 198 $223.82
93971 <1% 12 $207.26
J2704 Injection, propofol, 10 mg <1% 144 $175.52
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,985 $82.30
82805 <1% 14 $81.08
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 210 $67.38
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 74 $62.64
96376 <1% 1,247 $58.54
83615 <1% 76 $18.71
S0028 Injection, famotidine, 20 mg <1% 792 $10.48
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,609 $5.55
82248 <1% 34 $1.48
84132 0% 30 $0.00
J2060 Injection, lorazepam, 2 mg 0% 526 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 1,137 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 207 $0.00
J3490 Unclassified drugs 0% 128 $0.00
87147 0% 14 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 74 $0.00
86308 0% 12 $0.00
82550 0% 45 $0.00
J1815 Injection, insulin, per 5 units 0% 114 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 13 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 51 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 12 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 309 $0.00
C1758 Catheter, ureteral 0% 44 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 17 $0.00
00840 0% 27 $0.00
82375 0% 14 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 18 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 99 $0.00
29125 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPINTOZZI, KERI (CFO)